Skip to main content

Theralase Technologies Inc(TLT-X)
TSX Venture

Today's Change
Delayed Last Update

Theralase Announces Leadership Reorganization

Globe Newswire - Mon Nov 15, 2021

TORONTO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDC”) and associated drug formulations, announced today the following leadership reorganization:

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe